$2.42
+0.12 (+5.22%)
Open$2.31
Previous Close$2.30
Day High$2.43
Day Low$2.31
52W High$32.18
52W Low$17.76
Volume—
Avg Volume466.7K
Market Cap136.34M
P/E Ratio31.91
EPS$0.88
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,195.0% upside
Current
$2.42
$2.42
Target
$31.34
$31.34
$21.51
$31.34 avg
$48.77
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 31.09M | 30.93M | 26.54M |
| Net Income | -7,654,277 | -5,880,957 | -4,950,304 |
| Profit Margin | -24.6% | -19.0% | -18.7% |
| EBITDA | -10,459,331 | -8,827,347 | -7,842,890 |
| Free Cash Flow | -9,100,252 | -6,633,459 | -6,096,996 |
| Rev Growth | +19.1% | +18.4% | +23.2% |
| Debt/Equity | 0.34 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |